87 related articles for article (PubMed ID: 16801070)
1. Inhibitory effect of glyburide on thrombin-induced platelet aggregation and phosphoinositide metabolism in normal human platelets.
Wada H; Ishizuka T; Itaya S; Yamada K; Kajita K; Kimura M; Miura A; Shibata T; Kanoh Y; Ishizawa M; Yasuda K
Platelets; 1999; 10(1):45-51. PubMed ID: 16801070
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced platelet aggregation, phosphoinositide metabolism and protein phosphorylation in NIDDM patients treated by diet, sulphonylurea or insulin.
Ishizuka T; Taniguchi O; Yamamoto M; Kajita K; Nagashima T; Takeda N; Inouye H; Yasuda K; Miura K
Diabetologia; 1994 Jun; 37(6):632-8. PubMed ID: 7926350
[TBL] [Abstract][Full Text] [Related]
3. Changes in Phosphoinositides in Rabbit Platelets during Clot Formation. Comparison of Platelets Stimulated by ADP or by Thrombin in the Presence of Polymerising Fibrin.
Vickers JD; Kinlough-Rathbone RL; Packham MA; Mustard JF
Platelets; 1990; 1(4):199-204. PubMed ID: 21043948
[TBL] [Abstract][Full Text] [Related]
4. Microbubble-induced phospholipase C activation does not correlate with platelet aggregation.
Malmgren R; Thorsen T; Nordvik A; Holmsen H
Thromb Haemost; 1993 Apr; 69(4):394-6. PubMed ID: 8388581
[TBL] [Abstract][Full Text] [Related]
5. Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro.
Avcu F; Ural AU; Cetin T; Nevruz O
Thromb Res; 2008; 121(4):567-71. PubMed ID: 17910980
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory mechanism of human platelet aggregation by nafamostat mesilate.
Fuse I; Higuchi W; Toba K; Aizawa Y
Platelets; 1999 Jul; 10(4):212-8. PubMed ID: 16801094
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation in obese and diabetic subjects: association with leptin level.
Sugiyama C; Ishizawa M; Kajita K; Morita H; Uno Y; Matsubara K; Matsumoto M; Ikeda T; Ishizuka T
Platelets; 2007 Mar; 18(2):128-34. PubMed ID: 17365861
[TBL] [Abstract][Full Text] [Related]
8. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
9. Experimental diabetes and platelet aggregation in the rat.
Murray J; Kaneko JJ; Rucker RB
Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):283-91. PubMed ID: 6356254
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids.
Broekman MJ; Ward JW; Marcus AJ
J Clin Invest; 1980 Aug; 66(2):275-83. PubMed ID: 7400315
[TBL] [Abstract][Full Text] [Related]
11. Changes in phosphoinositide turnover, Ca2+ mobilization, and protein phosphorylation in platelets from NIDDM patients.
Ishii H; Umeda F; Hashimoto T; Nawata H
Diabetes; 1990 Dec; 39(12):1561-8. PubMed ID: 2174010
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin A1 inhibits increases in intracellular calcium concentration, TXA(2) production and platelet activation.
Zhu Y; Gu ZL; Liang ZQ; Zhang HL; Qin ZH
Acta Pharmacol Sin; 2006 May; 27(5):549-54. PubMed ID: 16626509
[TBL] [Abstract][Full Text] [Related]
13. In vitro Effect of Verapamil on Platelet Activation Induced by ADP, Collagen or Thrombin.
Brocchieri A; Pacchiarini L; Saporiti A; Grignani G
Platelets; 1995; 6(4):195-9. PubMed ID: 21043728
[TBL] [Abstract][Full Text] [Related]
14. Decreased arachidonic acid liberation participates in the anti-aggregatory effect of the histamine H(1)-receptor antagonist Bromadryl.
Jacinová V; Nosál R; Danihelová E
Platelets; 1999; 10(6):391-8. PubMed ID: 16801118
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP.
Lee WM; Kim SD; Park MH; Cho JY; Park HJ; Seo GS; Rhee MH
J Pharm Pharmacol; 2008 Nov; 60(11):1531-6. PubMed ID: 18957175
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
17. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Thromb Res; 2009 Jun; 124(2):199-207. PubMed ID: 19327818
[TBL] [Abstract][Full Text] [Related]
18. Adenosine inhibition of adenosine diphosphate and thrombin-induced monocyte-platelet aggregates in cardiac syndrome X.
Aurigemma C; Scalone G; Fattorossi A; Sestito A; Lanza GA; Crea F
Thromb Res; 2009 May; 124(1):116-20. PubMed ID: 19185336
[TBL] [Abstract][Full Text] [Related]
19. The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin.
Tharmapathy P; Fukami MH; Holmsen H
Biochem Pharmacol; 2000 Nov; 60(9):1267-77. PubMed ID: 11008120
[TBL] [Abstract][Full Text] [Related]
20. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
